taxane and elesclomol

taxane has been researched along with elesclomol* in 1 studies

Other Studies

1 other study(ies) available for taxane and elesclomol

Article	Year
Drug evaluation: STA-4783--enhancing taxane efficacy by induction of Hsp70. Current opinion in investigational drugs (London, England : 2000), 2006, Volume: 7, Issue:6 The apoptosis stimulator STA-4783 acts by inducing expression of heat shock protein (Hsp)70 on tumor cell surfaces and disrupting the cytoskeletal network. Currently in development by Synta Pharmaceuticals for the potential treatment of solid tumors, phase II clinical trials in non-small-cell lung cancer, melanoma and sarcoma have been initiated. Topics: Animals; Antineoplastic Agents; Bridged-Ring Compounds; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Gene Expression Regulation, Neoplastic; HSP70 Heat-Shock Proteins; Humans; Hydrazines; Lung Neoplasms; Melanoma; RNA, Messenger; Taxoids; Tubulin Modulators	2006

Article

Year

Drug evaluation: STA-4783--enhancing taxane efficacy by induction of Hsp70.

Current opinion in investigational drugs (London, England : 2000), 2006, Volume: 7, Issue:6

The apoptosis stimulator STA-4783 acts by inducing expression of heat shock protein (Hsp)70 on tumor cell surfaces and disrupting the cytoskeletal network. Currently in development by Synta Pharmaceuticals for the potential treatment of solid tumors, phase II clinical trials in non-small-cell lung cancer, melanoma and sarcoma have been initiated.

Topics: Animals; Antineoplastic Agents; Bridged-Ring Compounds; Carcinoma, Non-Small-Cell Lung; Clinical Trials as Topic; Drug Evaluation, Preclinical; Drug Synergism; Drug Therapy, Combination; Gene Expression Regulation, Neoplastic; HSP70 Heat-Shock Proteins; Humans; Hydrazines; Lung Neoplasms; Melanoma; RNA, Messenger; Taxoids; Tubulin Modulators

2006